Additionally, plasma levels of Hsp90α are elevated in patients with malignant tumors compared to controls or those with benign tumors and are further elevated in those with metastatic breast cancer compared to localized disease (Wang et al., 2009). The gene discussed is HSP90AA1; the disease is cancer.